October 28-29, 2010 Meeting of the Transmissible Spongiform Encephalopathies Advisory Committee
Recent advances in development of devices to remove TSE agents from blood components(PPT - 124KB) [ARCHIVED]
Persons with disabilities having problems accessing the PowerPoint file may call 301-827-0314 for assistance.
Proposed BSE Comprehensive Rule: A New Approach to BSE Rulemaking(PPT - 391KB) [ARCHIVED]
Dr. Christopher Robinson
- USDA, APHIS BSE Surveillance Update (PPTX - 691KB) [ARCHIVED]
Troy Bigelow, DVM
Asahi Combination Filter, Sepacell PrimaTM for Prion and Leukocyte Reduction(PPT - 2.8MB) [ARCHIVED]
Tomo Yokomizo, Morikazu Miura
Evaluation of Prion Reduction Filters with a Highly Sensitive Cell Culture-Based Infectivity Assay(PPT - 2.4MB) [ARCHIVED]
Samuel Coker, PhD
Prion Reduction of Blood Components by Affinity Filtration(PPT - 5.9MB) [ARCHIVED]
Steven J. Burton Ph.D.